These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients. Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474 [TBL] [Abstract][Full Text] [Related]
23. Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years. Anagnostopoulos A; McKay VH; Cooper I; Campbell F; Greenhalgh L; Kirwan J Int J Gynecol Cancer; 2017 Jun; 27(5):931-937. PubMed ID: 28498244 [TBL] [Abstract][Full Text] [Related]
24. The clinical features and management of Lynch syndrome-associated ovarian cancer. Ran X; Jing H; Li Z J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369 [TBL] [Abstract][Full Text] [Related]
25. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306 [TBL] [Abstract][Full Text] [Related]
32. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026 [TBL] [Abstract][Full Text] [Related]
33. When to Consider Lynch Syndrome in Non-Colon and Non-Endometrial Malignancies. Arroyave AJ; Good AW; Ward AJ; Orucevic AL; McLoughlin JM Am Surg; 2023 May; 89(5):1912-1922. PubMed ID: 34247540 [TBL] [Abstract][Full Text] [Related]
34. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer. Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346 [TBL] [Abstract][Full Text] [Related]
35. DNA mismatch repair deficiency in endometrial carcinoma. Karamurzin Y; Rutgers JK Int J Gynecol Pathol; 2009 May; 28(3):239-55. PubMed ID: 19620942 [TBL] [Abstract][Full Text] [Related]
36. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply? D'Arcy C; Wen YH; Stadler ZK; Brogi E; Shia J Am J Surg Pathol; 2011 Nov; 35(11):1743-8. PubMed ID: 21997695 [TBL] [Abstract][Full Text] [Related]
37. Use of mismatch repair immunohistochemistry and microsatellite instability testing: exploring Canadian practices. Kalloger SE; Allo G; Mulligan AM; Pollett A; Aronson M; Gallinger S; Torlakovic EE; Clarke BA Am J Surg Pathol; 2012 Apr; 36(4):560-9. PubMed ID: 22301492 [TBL] [Abstract][Full Text] [Related]
38. Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression. Lee-Kong SA; Markowitz AJ; Glogowski E; Papadopoulos C; Stadler Z; Weiser MR; Temple LK; Guillem JG Clin Colorectal Cancer; 2010 Oct; 9(4):255-9. PubMed ID: 20920999 [TBL] [Abstract][Full Text] [Related]
39. The gynecological surveillance of women with Lynch syndrome in Sweden. Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554 [TBL] [Abstract][Full Text] [Related]